Monoclonal immunoscintigraphy for detection of metastasis and recurrence of colorectal cancer.

AIM To assess the clinical role of monoclonal immunoscintigraphy for the detection of metastasis and recurrence of colorectal cancer. METHODS Monoclonal immunoscintigraphy was performed in patients operated on for colorectal adenocarcinoma suspected of local recurrence and metastatic disease. The results were compared with conventional diagnostics. RESULTS Immunoscintigraphic investigation was done in 53 patients. Tumor recurrence occurred in 38 patients, and was confirmed by other diagnostic modalities in 35. In 15 patients, immunoscintigraphic findings were negative, and confirmed in 14 with other diagnostic methods. Comparative analysis confirmed good correlation of immunoscintigraphic findings and the results of conventional diagnostics and the level of tumor marker carcinoembryonic antigen. Statistical analysis of parameters of radiopharmaceutical groups imacis, indimacis and oncoscint presented homogenous characteristics all of three radiopharmaceuticals. The analysis of immunoscintigraphic target focus was clearly improved using tomography. CONCLUSION Immunoscintigraphy is highly specific and has a good predictive value in local recurrence of colorectal cancer.

[1]  W. Oyen,et al.  Pretargeted 177Lu Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colonic Tumors in Mice , 2010, The Journal of Nuclear Medicine.

[2]  W. Oyen,et al.  Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti‐di‐diethylenetriaminepentaacetic acid F(ab′)2 antibody , 2010, Cancer.

[3]  F. Lin,et al.  MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice. , 2010, Anticancer research.

[4]  Min-Hua Chen,et al.  Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. , 2010, Nuclear medicine and biology.

[5]  A. Vera,et al.  Metastases and Recurrence of Colorectal Cancer: Diagnostic Role of Immunoscintigraphy , 2009 .

[6]  D. Sobic-Saranovic,et al.  Is there a future role for immunoscintigraphy in the diagnosis of colorectal carcinoma? , 2009, Neoplasma.

[7]  R. Mansberg,et al.  Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  M. Knopp,et al.  Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer , 2007, World journal of surgical oncology.

[9]  A. CarolinaAqueveque,et al.  Utilidad clínica de la fusión SPECT/CT con marcadores externos en patología oncológica. , 2007 .

[10]  Carolina Aqueveque A,et al.  [Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake]. , 2007, Revista medica de Chile.

[11]  D. Sobic-Saranovic,et al.  Radioimmunoscintigraphy of colorectal carcinomas with three different radiopharmaceuticals. , 2006, Neoplasma.

[12]  Ora Israel,et al.  SPECT/CT in tumor imaging: technical aspects and clinical applications. , 2003, Seminars in nuclear medicine.

[13]  M. Taniguchi,et al.  [A case of lumbar intradural and epidural abscesses presenting with elevated serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9)]. , 2003, No to shinkei = Brain and nerve.

[14]  S. Pavlović,et al.  111 in labeled antibodies in the detection of colorectal carcinoma , 2003 .

[15]  S. Pavlović,et al.  [Indium 111-labeled antibodies in the detection of colorectal carcinoma]. , 2003, Acta chirurgica Iugoslavica.

[16]  F. Fama’,et al.  [Radioimmunoguided surgery (R.I.G.S.) in colorectal cancer. Preliminary results]. , 2002, Chirurgia italiana.

[17]  S. Shiesh,et al.  The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. , 2002, Hepato-gastroenterology.

[18]  K. Šmejkal,et al.  Immunoscintigraphy and intra‐operative radioimmunodetection in the treatment of colorectal carcinoma , 2001, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[19]  R. Offord,et al.  Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. , 2001, Cancer biotherapy & radiopharmaceuticals.

[20]  H. Biersack,et al.  FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Setoain,et al.  Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody. , 1999, Nuclear medicine communications.

[22]  L. Stocchi,et al.  Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer , 1998, Diseases of the colon and rectum.

[23]  D. Goldenberg.  Perspectives on oncologic imaging with radiolabeled antibodies , 1997, Cancer.

[24]  Katsuki Ito,et al.  [Diagnosis of local recurrence of colorectal cancer, using PET and immunoscintigraphy by means of 131I or 111In anti-CEA monoclonal antibody]. , 1997, Nihon Geka Gakkai zasshi.

[25]  Berman,et al.  Radioimmunodetection of Colorectal Carcinoma. , 1996, Cancer control : journal of the Moffitt Cancer Center.

[26]  V. Cronin,et al.  Superiority of SPET to planar imaging in the detection of colorectal carcinomas with 111In monoclonal antibodies , 1995, Nuclear medicine communications.

[27]  D. Kahn,et al.  Detection of Recurrent Colorectal Carcinoma With In‐111 CYT‐103 Scintigraphy in a Patient With Nondiagnostic MRI and CT , 1994, Clinical nuclear medicine.

[28]  M. Tempero.  Pitfalls in antibody imaging in colorectal cancer , 1993, Cancer.

[29]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[30]  G. Winzelberg,et al.  Indium‐111 monoclonal antibody b72.3 scintigraphy in colorectal cancer correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response , 1992, Cancer.

[31]  P. Schlag,et al.  Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences. , 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  L. Roveda.  [Radioimmunoscintigraphy with monoclonal antibodies in recurrences and metastases of colorectal tumors]. , 1990, Medicina.

[33]  P. Riva,et al.  Immunoscintigraphy of primary and metastatic colorectal cancers with radiolabelled monoclonal antibodies anti-CEA. , 1989, Acta gastro-enterologica Belgica.

[34]  P. Schlag,et al.  The value of immunoscintigraphy for the operative retreatment of colorectal cancer. Limitations of a new diagnostic method , 1989, Cancer.

[35]  P. Schlag,et al.  [Current role of immunoscintigraphy for surgical therapy of the recurrence of colorectal cancers]. , 1987, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[36]  G. Mariani,et al.  Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody. , 1987, Cancer Detection and Prevention.

[37]  V. Kholin,et al.  [Current state and approaches to increasing the effectiveness of combined radiotherapy of uterine cancer]. , 1986, Meditsinskaia radiologiia.

[38]  A. Perkins,et al.  lmmunoscintigraphy for colorectal cancer , 1986 .

[39]  A. Thor,et al.  Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. , 1986, Cancer research.

[40]  J. Schlom,et al.  Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. , 1986, Cancer research.

[41]  P. Hand,et al.  A spectrum of monoclonal antibodies reactive with human mammary tumor cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.